Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Janssen discloses DHODH inhibitors

Dec. 17, 2021

Targeting S100A7/RAGE signaling pathway inhibits breast tumorigenesis

Dec. 17, 2021

BridGene and Peter MacCallum Cancer Centre enter research collaboration for ovarian cancer

Dec. 16, 2021

Targeting LIF/LIFR axis as potential therapeutic strategy against adiposity-driven TNBC

Dec. 16, 2021

Senda Biosciences presents AhR antagonists for cancer

Dec. 16, 2021

G1 Therapeutics discloses new CDK2 inhibitors

Dec. 16, 2021

YES1 seen to induce the growth of TNBC

Dec. 16, 2021

Targeting cyclophilin A potentiates chemotherapeutic efficacy in chemoresistant colorectal cancer

Dec. 16, 2021

MK2 is a therapeutic target in PDAC that mediates resistance to FIRINOX chemotherapy

Dec. 16, 2021

Targeting NSDHL could prevent breast cancer initiation and progression

Dec. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...